CD44 and breast cancer: Reports from others demonstrate that Notch4 signaling is elevated in CD44+/CD24− cells and that inhibiting this pathway reduces mammosphere formation and prevents tumor initiation in vivo identifying Notch4 as a critical regulator of breast cancer TICs [24, 31].